Christopher Scott Hill

Insider Reports History

Location
Houston, TX
Signature
/s/ Mark Tattoli, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Scott Hill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Core Laboratories Inc. /DE/ SVP & CFO Common Stock 142,354 $2,421,441 $17.01 31 Dec 2025 Direct
CORE LABORATORIES N V SVP & CFO Common Shares 62,642 31 Dec 2022 Direct
CORE LABORATORIES N V SVP & CFO Performance Shares 52,718 16 Feb 2023 Direct
CORE LABORATORIES N V SVP & CFO Common Shares 59 31 Dec 2022 401(k) Plan
Core Laboratories Inc. /DE/ SVP & CFO Performance Shares 0 31 Dec 2025 Direct

Insider Reports Filed by Christopher Scott Hill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLB Core Laboratories Inc. /DE/ 31 Dec 2025 3 -$515,397 4 SVP & CFO 05 Jan 2026, 15:17
CLB Core Laboratories Inc. /DE/ 13 Feb 2025 1 $0 4 SVP & CFO 13 Feb 2025, 16:37
CLB Core Laboratories Inc. /DE/ 31 Dec 2024 3 -$254,786 4 SVP & CFO 03 Jan 2025, 16:59
CLB Core Laboratories Inc. /DE/ 15 Feb 2024 1 $0 4 SVP & CFO 15 Feb 2024, 16:11
CLB Core Laboratories Inc. /DE/ 31 Dec 2023 1 -$250,684 4/A SVP & CFO 08 Jan 2024, 14:49
CLB Core Laboratories Inc. /DE/ 31 Dec 2023 3 -$244,944 4 SVP & CFO 03 Jan 2024, 17:43
/report/000120919123011099-hill-christopher-scott-2023-02-16 CORE LABORATORIES N V 16 Feb 2023 1 $0 4 SVP & CFO 21 Feb 2023, 14:20
/report/000120919123001028-hill-christopher-scott-2022-12-31 CORE LABORATORIES N V 31 Dec 2022 3 -$252,767 4 SVP & CFO 04 Jan 2023, 15:55
/report/000120919122010862-hill-christopher-scott-2022-02-17 CORE LABORATORIES N V 17 Feb 2022 1 $0 4 SVP & CFO 17 Feb 2022, 16:08
/report/000120919122001068-hill-christopher-scott-2021-12-31 CORE LABORATORIES N V 31 Dec 2021 3 -$206,568 4 SVP & CFO 04 Jan 2022, 16:55